Genetic variants in fanconi anemia pathway genes BRCA2 and FANCA predict melanoma survival

Journal of Investigative Dermatology

Volumn 135, Issue 2, 2015, Pages 542-550

  Yin, Jieyun ^a,b   Liu, Hongliang ^a   Liu, Zhensheng ^a   Wang, Li E ^c   Chen, Wei V ^c   Zhu, Dakai ^d   Amos, Christopher I ^d   Fang, Shenying ^c   Lee, Jeffrey E ^c   Wei, Qingyi ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; FANCONI ANEMIA GROUP A PROTEIN; FANCA PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRCA2 GENE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; CUTANEOUS MELANOMA; DISEASE ASSOCIATION; FALSE POSITIVE RESULT; FANCA GENE; FANCONI ANEMIA; FEMALE; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME; BIOLOGY; GENETIC VARIATION; GENETICS; MELANOMA; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; SKIN TUMOR; TUMOR SUPPRESSOR GENE; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMPUTATIONAL BIOLOGY; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP A PROTEIN; FEMALE; GENES, BRCA2; GENETIC VARIATION; HUMANS; MALE; MELANOMA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; ROC CURVE; SKIN NEOPLASMS;

EID: 84929504750     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.416     Document Type: Article

References (43)

1. Alexander BM, Wang XZ, Niemierko A et al. (2012) DNA repair biomarkers predict response to neoadjuvant chemoradiotherapy in esophageal cancer. Int J Radiat Oncol Biol Phys 83:164-71
2. Amos CI, Wang LE, Lee JE et al. (2011) Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum Mol Genet 20:5012-23
3. Aulchenko YS, Ripke S, Isaacs A et al. (2007) GenABEL: an R library for genome-wide association analysis. Bioinformatics 23:1294-96
4. Balch CM, Gershenwald JE, Soong SJ et al. (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27:6199-206
5. Bauer VL, Braselmann H, Henke M et al. (2008) Chromosomal changes characterize head and neck cancer with poor prognosis. J Mol Med 86:1353-65
6. Berhane H, Epperly MW, Goff J et al. (2014) Radiologic differences between bone marrow stromal and hematopoietic progenitor cell lines from Fanconi Anemia (Fancd2(-/-)) mice. Radiat Res 181:76-89
7. Chin L, Garraway LA, Fisher DE (2006) Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev 20:2149-82
8. Crossan GP, Patel KJ (2012) The Fanconi anaemia pathway orchestrates incisions at sites of crosslinked DNA. J Pathol 226:326-7
9. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837-45
10. Emmert S, Kraemer KH (2013) Do not underestimate nucleotide excision repair: it predicts not only melanoma risk but also survival outcome. J Investig Dermatol Symp Proc 133:1713-7
11. Ghosh A, Maiti GP, Bandopadhyay MN et al. (2013) Inactivation of 9q22.3 tumor suppressor genes predict outcome for patients with head and neck squamous cell carcinoma. Anticancer Re 33:1215-20
12. Holm K, Melum E, Franke A et al. (2010) SNPexp - a web tool for calculating and visualizing correlation between HapMap genotypes and gene expression levels. BMC Bioinformatics 11:600
13. Kao WH, Riker AI, Kushwaha DS et al. (2011) Upregulation of Fanconi anemia DNA repair genes in melanoma compared with non-melanoma skin cancer. J Investig Dermatol Symp Proc 131:2139-42
14. Kennedy RD, D'Andrea AD (2005) The Fanconi anemia/BRCA pathway: new faces in the crowd. Genes Dev 19:2925-40
15. Kottemann MC, Smogorzewska A (2013) Fanconi anaemia and the repair of Watson and Crick DNA crosslinks. Nature 493:356-63
16. Kupferman ME, Kubik MW, Bradford CR et al. (2014) The role of sentinel lymph node biopsy for thin cutaneous melanomas of the head and neck. Am J Otolaryngol 35:226-32
17. Lens MB, Dawes M (2004) Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 150:179-85
18. Li C, Yin M, Wang LE et al. (2013) Polymorphisms of nucleotide excision repair genes predict melanoma survival. J Investig Dermatol Symp Proc 133:1813-21
19. Li Y, Willer CJ, Ding J et al. (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34:816-34
20. Lim SL, Smith P, Syed N et al. (2008) Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer. Br J Cancer 98:1452-6
21. Liu H, Wei Q, Gershenwald JE et al. (2012) Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression. Melanoma Res 22:169-75
22. Mailman MD, Feolo M, Jin Y et al. (2007) The NCBI dbGaP database of genotypes and phenotypes. Nat Genet 39:1181-6
23. Matakidou A, el Galta R, Webb EL et al. (2007) Genetic variation in the DNA repair genes is predictive of outcome in lung cancer. Hum Mol Genet 16:2333-40
24. Moldovan GL, D'Andrea AD (2009) How the fanconi anemia pathway guards the genome. Annu Rev Genet 43:223-49
25. Mulligan JM, Hill LA, Deharo S et al. (2014) Identification and validation of an anthracycline/cyclophosphamide-based chemotherapy response assay in breast cancer. J Natl Cancer Inst 106:djt335
26. Munshi A, Kurland JF, Nishikawa T et al. (2005) Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. Clin Cancer Res 11:4912-22
27. Nakanishi R, Kitao H, Fujinaka Y et al. (2012) FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer. Ann Surg Oncol 19:3627-5
28. Nitta M, Kozono D, Kennedy R et al. (2010) Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy. PLoS ONE 5:e10767
29. Ozawa H, Iwatsuki M, Mimori K et al. (2010) FANCD2 mRNA overexpression is a bona fide indicator of lymph node metastasis in human colorectal cancer. Ann Surg Oncol 17:2341-8
30. Rendleman J, Shang S, Dominianni C et al. (2013) Melanoma risk loci as determinants of melanoma recurrence and survival. J Transl Medicine 11:279
31. Rudland PS, Platt-Higgins AM, Davies LM et al. (2010) Significance of the Fanconi anemia FANCD2 protein in sporadic and metastatic human breast cancer. Am J Pathol 176:2935-47
32. Sabel MS (2012) Sentinel lymph node biopsy for thin melanoma-con. J Surg Oncol 106:217-8
33. Sanlorenzo M, Ribero S, Osella-Abate S et al. (2013) Melanoma in patients younger than 20 years. G Ital Dermatol Venereol 148:667-72
34. Schramm SJ, Mann GJ (2011) Melanoma prognosis: a REMARK-based systematic review and bioinformatic analysis of immunohistochemical and gene microarray studies. Mol Cancer Ther 10:1520-8
35. Siegel R, Ma J, Zou Z et al. (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9-29
36. Sinha S, Singh RK, Alam N et al. (2008) Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: pathological significance in early- and late-onset breast carcinoma. Mol Cancer 7:84
37. Stoepker C, Hain K, Schuster B et al. (2011) SLX4, a coordinator of structurespecific endonucleases, is mutated in a new Fanconi anemia subtype. Nat Genet 43:138-41
38. Swarts DR, Van Neste L, Henfling ME et al. (2013) An exploration of pathways involved in lung carcinoid progression using gene expression profiling. Carcinogenesis 34:2726-37
39. Swisher EM, Gonzalez RM, Taniguchi T et al. (2009) Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas. Mol Cancer 8:48
40. van der Groep P, Hoelzel M, Buerger H et al. (2008) Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer. Breast Cancer Res Treat 107:41-7
41. von Thaler AK, Kamenisch Y, Berneburg M (2010) The role of ultraviolet radiation in melanomagenesis. Exp Dermatol 19:81-8
42. Wacholder S, Chanock S, Garcia-Closas M et al. (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96:434-2
43. Xu Z, Taylor JA (2009) SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Re 37:W600-5